Screener
IDNA vs IBRN
iShares Genomics Immunology and Healthcare ETF vs iShares Neuroscience and Healthcare ETF
Key differences
- IDNA is significantly larger than IBRN — larger funds tend to be more liquid and less likely to close.
- Over the last 3 years, IBRN has delivered higher annualized returns.
Side-by-side comparison
| IDNA | IBRN | |
|---|---|---|
| Annual cost (TER) | 0.47% | 0.47% |
| Fund size (AUM) | $160M | $5M |
| Since | 2019 | 2022 |
| Dividend yield | 1.05% | 0.93% |
| Asset class | equity | equity |
| Region | — | — |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +49.2% | +56.8% |
| CAGR 3Y | +8.0% | +10.6% |
| CAGR 5Y | -7.5% | N/A |
| Sharpe 3Y | 0.29 | 0.39 |
| Volatility 1Y | 24.43% | 25.00% |
| Max drawdown | -68.26% | -35.39% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to IDNA and IBRN
Explore further